150
Participants
Start Date
February 24, 2024
Primary Completion Date
May 31, 2026
Study Completion Date
May 31, 2027
Revi System Treatment
The Revi System is an implantable neuromodulation device placed in the ankle region that is activated by a battery-operated rechargeable external wearable
Revi System - Delayed Activation
The Revi System is an implantable neuromodulation device placed in the ankle region that is activated by a battery-operated rechargeable external wearable. The system will be implanted but it will not be turned on until 4 months post implant procedure.
RECRUITING
Montefiore Medical Center, The Bronx
RECRUITING
Chesapeake Urology, Owings Mills
RECRUITING
Florida Urology Partners, Tampa
RECRUITING
University of Alabama at Birmingham, Birmingham
RECRUITING
University Hospitals Cleveland Medical Center, Cleveland
RECRUITING
Sanford Female Pelvic Medicine & Reconstructive Surgery Clinic, Sioux Falls
RECRUITING
Specialty Clinical Research of St. Louis, LLC, St Louis
RECRUITING
Adult and Pediatric Urology and Urogynecology, Omaha
RECRUITING
Willis-Knighton Clinical Research, Shreveport
RECRUITING
University of Texas Southwestern - Department of Urology, Dallas
RECRUITING
Urology Partners of North Texas, Arlington
RECRUITING
The Urology Place, San Antonio
RECRUITING
DHR Health Institute for Research and Development, Edinburg
RECRUITING
University of Utah, Salt Lake City
RECRUITING
Arizona Urology Specialists, Tucson
RECRUITING
Pasadena Urology, Pasadena
RECRUITING
Riverside Medical Clinic, Riverside
Lead Sponsor
BlueWind Medical
INDUSTRY